IntelliCell BioSciences, Inc.
Investment Research Report Issued
Read Report – http://www.princetonresearch.com/Intellicell-3-2012.pdf
IntelliCell BioSciences, Inc. (Symbol: SVFC) can treat joint pain without painful surgery. They are the only public commercial stem cell company in the United States. IntellicellTM is the only company in the U.S. to meet FDA (Law 361) guidelines for this procedure.
The Company is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using stromal vascular fraction derived from adult adipose tissue. IntelliCell intends to initially focus on selling laboratory suites and licensing its technology to doctors for use in their offices for their patients.
The company is also setting up Centers of Excellence where doctors can treat their patients. In addition, IntelliCell BioScience in exploring storing the stromal vascular fraction in cryostorage for future uses. The company is also starting FDA IND clinical trials at major medical centers for clinical indication approval.
IntelliCell intends to pursue expansion to secondary markets and beyond the U.S. through a combination of company-owned and licensed clinical facilities.
For additional information, visit http://www.intellicellbiosciences.com or call 212-249-3050.
Corporate Website: http://www.intellicellbiosciences.com
IntellicellTM Facts: http://www.intellicellbiosciences.com/intellicell-facts.html
Stock Quote and Trading Chart:
Feb 21, 2012 – Businesswire: IntelliCell BioScience Inc. Procedure Enables Norwegian Star Basketball Player to Fully Recover from Patella Tendinitis to Play for Manhattan College – Read News – http://finance.yahoo.com/news/IntelliCell-BioScience-Inc-bw-1776052445.html?x=0